An Integrated Care Model for Pregnant and Postpartum Individuals Receiving Medication for Opioid Use Disorder

被引:15
|
作者
Ellis, Laura Peyton [1 ]
Parlier-Ahmad, Anna Beth [2 ]
Scheikl, Marjorie [3 ,4 ]
Martin, Caitlin E. [3 ,4 ,5 ]
机构
[1] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA
[2] Virginia Commonwealth Univ, Dept Psychol, Richmond, VA USA
[3] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA
[4] Virginia Commonwealth Univ, Inst Drug & Alcohol Studies, Richmond, VA USA
[5] 1101 East Marshall St,11th Floor,Room 11-027,Box 9, Richmond, VA 23298 USA
关键词
addiction; integrated care; opioid use disorder; postpartum; pregnancy; ASSISTED TREATMENT; WOMEN; DEPENDENCE; RETENTION; OUTCOMES;
D O I
10.1097/ADM.0000000000001052
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
ObjectivesPerinatal opioid use disorder is increasing. Integrated obstetric/addiction care models likely optimize parent-infant dyad outcomes, but the ideal combination of services is unknown. This study (1) describes pregnancy-to-postpartum service utilization by people receiving buprenorphine at an integrated Obstetric/Addiction Clinic and (2) explores the association between service utilization and postpartum buprenorphine continuation.MethodsThis retrospective medical record review study uses research registry data from an outpatient Obstetric/Addiction Clinic. All patients are invited to participate in the research registry. For patients who consent, monthly medical record abstractions are conducted beginning with their first clinic visit to collect demographic, obstetric, and substance use disorder treatment variables. Present analyses included patients who delivered an infant between June 2019 and June 2021, started buprenorphine during pregnancy, and were receiving buprenorphine at delivery. Overall service utilization was the number of services (range 0-12) used between 28-weeks gestation and 12-weeks postpartum. Bivariate analyses and multivariable logistic regression assessed associations between service utilization and buprenorphine continuation.ResultsParticipants (n = 42) were primarily non-Latinx White (67%) with comorbid psychiatric diagnoses (95%). On average, participants used 6 services; prenatal care, mental health care, and postpartum contraception were most utilized. Overall, 69% of participants continued buprenorphine at 6 months postpartum. This did not differ by level of service utilization (bivariate [P = 0.07], multivariable [P = 0.16]).ConclusionIntegrated care with a harm reduction focus supports pregnancy-to-postpartum service utilization and buprenorphine continuation in a patient sample at high risk for medication for opioid use disorder discontinuation. Further work is needed to identify evidence-based methods to individualize integrated obstetric/addiction care.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [21] The impact of Medicaid expansion on postpartum health care utilization among pregnant women with opioid use disorder
    Patton, Briana P.
    Krans, Elizabeth E.
    Kim, Joo Yeon
    Jarlenski, Marian
    SUBSTANCE ABUSE, 2019, 40 (03) : 371 - 377
  • [22] Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the US
    Curran, Laura
    Manuel, Jennifer
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2024, 126
  • [23] "Syndemic barriers to successful treatment outcomes for individuals receiving medication for opioid use disorder" (HD23)
    Kleinman, Mary
    Seitz-Brown, Christopher J.
    Bradly, Valerie D.
    Tralka, Hannah
    Anvari, Morgan
    Cole, Thomas
    Belcher, Annabelle
    Greenblatt, Aaron
    Magidson, Jessica F.
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2020, 15 (SUPPL 2):
  • [24] INDIVIDUALS RECEIVING METHADONE FOR MEDICATION-ASSISTED TREATMENT OF OPIOID USE DISORDER SHOW EVIDENCE OF RESPIRATORY DEPRESSION
    Finlay, M.
    Wilson, M.
    Erwin, J. A.
    Hansen, D. A.
    Layton, M. E.
    Quock, R. M.
    Van Dongen, H.
    SLEEP, 2020, 43 : A278 - A278
  • [25] Comparison of Weaning and Nonweaning of Medication-Assisted Treatments in Pregnant and Postpartum Women With Opioid Use Disorder: A Systematic Review
    Adelli, Rakesh
    Olsen, Martin
    Ramirez, Andrea
    Shah, Darshan
    Subbanna, Maya
    Walker, McKenzie
    OBSTETRICS AND GYNECOLOGY, 2023, 141 : 5S - 5S
  • [26] Listening to women and pregnant and postpartum people: Qualitative research to inform opioid use disorder treatment for pregnant and postpartum people
    Guille, Constance
    Hall, Casey
    King, Courtney
    Sujan, Ayesha
    Brady, Kathleen
    Newman, Roger
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2022, 3
  • [27] Collaborative care programs for pregnant and postpartum individuals with opioid use disorder: Organizational characteristics of sites participating in the NIDA CTN0080 MOMs study
    Kropp, Frankie B.
    Smid, Marcela C.
    Lofwall, Michelle R.
    Wachman, Elisha M.
    Martin, Peter R.
    Murphy, Sean M.
    Wilder, Christine M.
    Winhusen, T. John
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2023, 149
  • [28] Impact of Medication-Based Treatment on Health Care Utilization Among Individuals With Opioid Use Disorder
    Gopaldas, Manesh
    Wenzel, Kevin
    Campbell, Aimee N. C.
    Jalali, Ali
    Fishman, Marc
    Rotrosen, John
    V. Nunes, Edward
    Murphy, Sean M.
    PSYCHIATRIC SERVICES, 2023, 74 (12) : 1227 - 1233
  • [29] Midwifery Care of Pregnant Individuals Experiencing Opioid use Disorder: Changing Regulations, Complexities, and Call to Action
    Bukowski, Hannah Bartee
    Combellick, Joan L.
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2022, 67 (06) : 770 - 776
  • [30] Postpartum Follow-up Care for Pregnant Persons With Opioid Use Disorder and Hepatitis C Virus Infection
    Jarlenski, Marian
    Chen, Qingwen
    Ahrens, Katherine A.
    Allen, Lindsay
    Austin, Anna E.
    Chappell, Catherine
    Donohue, Julie M.
    Hammerslag, Lindsay
    Lanier, Paul
    McDuffie, Mary Joan
    Talbert, Jeffrey
    Tang, Lu
    Krans, Elizabeth E.
    OBSTETRICS AND GYNECOLOGY, 2022, 139 (05): : 916 - 918